Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis
Y Ma1
11] Lieber Institute for Brain Development, Johns Hopkins University School of Medicine, Baltimore, MD, USA [2] Psychological and brain sciences, Dartmouth College, Hanover, NH, USA.
Molecular Psychiatry
|March 26, 2014
Summary
Antidepressants normalize brain activity in emotional networks for depression treatment. This meta-analysis reveals how these drugs impact brain responses to positive and negative emotions in patients and healthy individuals.
Area of Science:
- Neuroimaging
- Psychiatry
- Neuroscience
Background:
- Antidepressants are common treatments for depression, but their precise effects on brain activity remain unclear.
- Previous neuroimaging studies show inconsistent results regarding antidepressant efficacy.
- The underlying neuropsychological mechanisms of antidepressant action need further specification.
Purpose of the Study:
- To systematically meta-analyze pharmacological neuroimaging studies on antidepressant effects on human brain activity.
- To investigate how antidepressants influence emotional processing in both patients with mood disorders and healthy volunteers.
- To clarify the neural mechanisms of antidepressant action in depression.
Main Methods:
- Quantitative Activation Likelihood Estimation (ALE) meta-analysis of 60 functional magnetic resonance imaging (fMRI) studies.
- Inclusion of studies published before February 2013, involving 1569 subjects.
- Stratification of results by population (patients/healthy volunteers), emotional valence (positive/negative), and treatment effects (increased/decreased activity).
Main Results:
- Antidepressants modulated activity in medial prefrontal and limbic regions (amygdala, thalamus) in response to emotional stimuli.
- In patients, antidepressants increased dorsolateral prefrontal cortex (dlPFC) activity, crucial for emotion regulation.
- In healthy volunteers, antidepressants decreased activity in reward-related areas (nucleus accumbens, midbrain) for positive emotions.
Conclusions:
- Antidepressants appear to normalize neural responses in depression by enhancing activity to positive stimuli and reducing it to negative stimuli.
- Increased dlPFC engagement suggests improved emotion regulation with antidepressant treatment.
- Findings highlight distinct effects in patients versus healthy individuals, informing treatment strategies.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Depressive Disorders: Etiology
884
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
884
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K


